Casimir Jones S.C. has developed and maintained Regenics broad IP strategy having secured a large number of patents and patents pending, covering wound healing and cosmetic applications of both LEX® and Vernex™ as well as products under development in the US, Europe and Rest of the world. That means Regenics is enjoying freedom to operate, is non-infringent in all aspects of its business and has secured transactional value from its operations and products.

Casimir Jones S.C. is a Madison, Wisconsin based law firm that fulfills the intellectual property needs of their local, national, and international clients. Casimir Jones take tremendous care and pleasure in developing and protecting the intellectual property rights of each of their clients. Their expertise permits them to work closely with their clients and drives their desire to assist each client to realize value via intellectual property. Casimir Jones attorneys possess an extensive and successful patent litigation record with the United States District Court, Western District of Wisconsin, as well as other courts around the country. Casimir Jones, S.C. provides services and counseling in many different fields of technology, and enjoys a specialized depth of knowledge and experience in the life sciences, medical device, and related fields.


Contact information:

2275 Deming Way, Suite 310
Middleton, Wisconsin 53562


Regenics' contact person:
Mitchell Jones, JD, PhD
Patent Attorney (US)

For more info on Regenics AS Patent, Trademark  & Copyrights, please see: Investors/IP or contact

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.